Fertility and Sterility
Volume 90, Issue 5 , Pages 2004.e19-2004.e21 , November 2008

Ovarian response in women undergoing ovarian stimulation after myomectomy

  • Hyacinth Browne, M.D.

      Affiliations

    • Program in Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
    • Reproductive Endocrinology and Infertility, Walter Reed Army Medical Center, Washington, D.C
    • Corresponding Author InformationReprint requests: Hyacinth Browne, M.D., Program in Reproductive and Adult Endocrinology, NICHD, CRC 1 East Rm 1-E-3140, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892 (FAX: 301-402-0884).
    • ,
  • Desiree McCarthy-Keith, M.D., M.P.H.

      Affiliations

    • Program in Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
    • Reproductive Endocrinology and Infertility, Walter Reed Army Medical Center, Washington, D.C
    • ,
  • Barbara Stegmann, M.D., M.P.H.

      Affiliations

    • Program in Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
    • Reproductive Endocrinology and Infertility, Walter Reed Army Medical Center, Washington, D.C
    • ,
  • James Spies, M.D.

      Affiliations

    • Interventional Radiology Section, Department of Radiology, Georgetown University Hospital, Washington, D.C
    • ,
  • Alicia Armstrong, M.D., M.H.S.C.R.

      Affiliations

    • Program in Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
    • Reproductive Endocrinology and Infertility, Walter Reed Army Medical Center, Washington, D.C

Received 4 January 2008 ,Revised 3 April 2008 ,Accepted 3 April 2008.

References 

  1. Domenico L, Siskin G. Uterine artery embolization and infertility. Tech Vasc Interv Radiol. 2006;9:7–11
  2. Buttram V, Reiter R. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36:433–445
  3. Sudik R, Husch K, Steller J, Daume E. Fertility and pregnancy outcome after myomectomy in sterility patients. Euro J Obstet Gynecol Reprod Biol. 1996;65:209–214
  4. Bulletti C, DE Ziegler D, Levi Setti P, Cicinelli E, Polli V, Stefanetti M. Myomas, pregnancy outcome, and in vitro fertilization. Ann N Y Acad Sci. 2004;1034:84–92
  5. Eldar-Geva T, Meagher S, Healy D, MacLachlan V, Breheny S, Wood C. Effect of intramural, subserosal and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment. Fertil Steril. 1998;70:687–691
  6. Farhi J, Ashkenazi J, Feldberg D, Dicker D, Orvieto R, Ben Rafael Z. Effect of uterine leiomyomata on the results of in vitro fertilization treatment. Hum Reprod. 1995;10:2576–2578
  7. Stovall D, Parrish S, Van Voorhis B, Hahn S, Sparks A, Syrop C. Uterine leiomyomas reduce the efficacy of assisted reproduction cycles: results of a matched follow-up study. Hum Reprod. 1998;13:192–197
  8. Feinberg E, Larsen F, Catherino W, Zhang J, Armstrong A. Comparison of assisted reproductive technology utilization and outcomes between caucasian and African-American patients in an equal-access-to-care setting. Fertil Steril. 2006;85:888–894
  9. Hovsepian D, Ratts V, Rodriguez M, Huang J, Aubuchon M, Pilgram T. A prospective comparison of the impact of uterine artery embolization, myomectomy, and hysterectomy on ovarian function. J Vasc Interv Radiol. 2006;17:1111–1115
  10. Spies J, Roth A, Gonsalves S, Murphy-Skrzyniarz K. Ovarian function after uterine artery embolization for leiomyomata: assessment with use of serum follicle stimulating hormone assay. J Vasc Interv Radiol. 2001;12:437–442
  11. Hehenkamp W, Volkers N, Broekmans F, de Jong F, Themmen A, Birnie E. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod. 2007;22:1996–2005
  12. van Rooij I, Broekmans F, te Velde E, Fauser B, Bancsi L, de Jong F. Serum antimullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17:3065–3071
  13. Ficicioglu C, Kutlu T, Demirbasoglu S, Mulayim B. The role of inhibin B as a basal determinant of ovarian reserve. Gynecol Endocrinol. 2003;17:287–293
  14. Broekmans F, Kwee J, Hendriks D, Mol B, Lambalk C. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685–718

 H.B. has nothing to disclose. D.M.-K. has nothing to disclose. B.S. has nothing to disclose. J.S. has nothing to disclose. A.A. has nothing to disclose.

 Carried out under Walter Reed Army Medical Center Department of Clinical Investigations protocol WU #08-04-44018hEX(1) and supported in part by the Program in Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health.

PII: S0015-0282(08)00799-1

doi: 10.1016/j.fertnstert.2008.04.008

Fertility and Sterility
Volume 90, Issue 5 , Pages 2004.e19-2004.e21 , November 2008

Article Tools